Thank you @Forbes for featuring @FemHealthVC and highlighting that the firm's focus on innovation delivers for both investors and patients!
https://t.co/1KS2xVrOEW
Our President and CEO, @gtmayes was featured in the @WSJ discussing @ReunionNeuro $103 million Series A financing for our ongoing RECONNECT Phase 2 trial (https://t.co/VxKspDuXdw) to help bring a novel treatment to women suffering from moderate to severe postpartum depression.
Read full article here: https://t.co/HElt5HHahu
A recent article by The Wall Street Journal discusses Thermo Fisher’s blood test that has recently become the first test to be cleared by the FDA for predicting life-threatening preeclampsia during pregnancy.
#Healthcare#Womenshealth#VC#Femhealth
https://t.co/dL0bkkiKA5
A recent article by the World Health Organization reveals that 1 in 6 people suffer from infertility and despite its prevalence, solutions are underfunded and largely inaccessible.
#InfertilityAwarenessWeek#Healthcare#Womenshealth#Femtech
https://t.co/NblFMBqKbM
President Biden’s “Cancer Moonshot” initiative aims to cut cancer deaths in half in the next 25 years. Breakthrough technologies such as 3D mammography and AI cancer pathology are addressing this goal.
#Healthcare#Womenshealth
https://t.co/YdOf2mni7a
A recent article by The Harvard Gazette explains the implications of new FDA guidelines which will require doctors to disclose a patient’s breast density at mammogram clinics.
#Healthcare#WomensHealth
https://t.co/wxTl6mQFLg
A recent article by NPR reveals the gender gap that exists within the health care sector, which was only worsened by the pandemic.
#Healthcare#Womenshealth
https://t.co/zdY4scu7mi
A recent article by the New York Times reveals that the U.S maternal mortality rate in 2021 was 60% greater than that of 2019—one key cause being COVID-19. Pregnant women with Covid face a sevenfold risk of dying compared to uninfected pregnant women.
https://t.co/rsxBJIn3l3